Stay updated on Sacituzumab Govitecan in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page revision/version indicator in the footer was updated from v3.5.2 to v3.5.3, reflecting an incremental site update rather than a change to the study record details.
    Difference
    0.0%
    Check dated 2026-04-24T17:10:17.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Updated the revision from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T14:11:20.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    Padua, Italy 35128 was removed and Padova, Italy 35128 was added in the locations list.
    Difference
    0.0%
    Check dated 2026-04-10T08:54:57.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    - Page revised to version v3.5.0 with new timestamps (2026-03-12 and 2026-03-16). Previous revision v3.4.3 appears to have been removed.
    Difference
    0.1%
    Check dated 2026-03-19T20:53:36.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    Website revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-12T19:29:53.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page shows the addition of Revision: v3.4.2 and the deletion of Revision: v3.4.1 as part of a minor site version update. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-12T05:37:48.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Urothelial Cancer Clinical Trial page.